Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Information, Expiry & Status of FDA Orange Book Patents covering Dihydroergotamine

Client Email

Product

Dihydroergotamine
US Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

Bora Pharmaceuticals- Making success more certain.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

Contact Supplier

Axplora- The partner of choice for complex APIs.

Contact Supplier

Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

Contact Supplier

Dihydroergotamine

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

8 API Suppliers, 7 USDMF, 3 CEP/COS, 9 NDC API, 4 Listed Suppliers, $ API Reference Price

8 API Suppliers
7 USDMF
3 CEP/COS
9 NDC API
4 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

31 Drugs in Development

31 Drugs in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Imports

API Reference Price
API Exports
API Imports
FDF Imports

FINISHED DOSAGE FORMULATIONS

24 FDF Dossiers, 16 FDA Orange Book, 4 Europe, 2 Canada, 2 Listed Dossiers

24 FDF Dossiers
16 FDA Orange Book
4 Europe
2 Canada
2 Listed Dossiers

RELATED EXCIPIENT COMPANIES

2 Actylis, 1 Kerry, 1 Pluviaendo

2 Actylis
1 Kerry
1 Pluviaendo

EXCIPIENTS BY APPLICATIONS

3 Parenteral, 1 Coating Systems & Additives, 1 Topical, 1 Controlled & Modified Release, 1 Film Formers & Plasticizers

3 Parenteral
1 Coating Systems & Additives
1 Topical
1 Controlled & Modified Release
1 Film Formers & Plasticizers

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 18 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
18 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 3 Finished Drug Prices, 4 Annual Reports

1 US Medicaid Prescriptions
3 Finished Drug Prices
4 Annual Reports

MARKET PLACE

4 APIs, 1 FDF Dossiers

4 APIs
1 FDF Dossiers

PATENTS & EXCLUSIVITIES

6 US Patents, 1 US Exclusivities, 1 Health Canada Patents

6 US Patents
1 US Exclusivities
1 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 1 USP, 1 JP, 1 Others

3 EDQM
1 USP
1 JP
1 Others

$ API Ref.Price (USD/KG) : 196,288 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

6 All

01 6IMPEL PHARMS

filter Patent Number Reset all filters

6 All

01 19550036

02 19919117

03 110507295

04 110940278

05 111185497

06 111266799

filter API Patent Reset all filters

6 All

01 6Blank

filter FDF Patent Reset all filters

6 All

01 5Y

02 1Blank

filter Expiration Date Reset all filters

6 All

01 12032-09-05

02 12032-12-25

03 12033-01-23

04 12033-03-17

05 12036-11-05

06 12039-01-04

US Patents
US Exclusivities
Health Canada Patents

Product Main Page

01

IMPEL PHARMS

DIHYDROERGOTAMINE MESYLATE

Discovery on Target

Not Confirmed

IMPEL PHARMS

Country

Discovery on Target

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2039-01-04

DIHYDROERGOTAMINE MESYLATE

US Patent Number : 11185497

Drug Substance Claim :

Drug Product Claim :

Application Number : 213436

Patent Use Code : U-3218

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-01-04

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

IMPEL PHARMS

DIHYDROERGOTAMINE MESYLATE

Discovery on Target

Not Confirmed

IMPEL PHARMS

Country

Discovery on Target

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-03-17

DIHYDROERGOTAMINE MESYLATE

US Patent Number : 9919117

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 213436

Patent Use Code : U-3218

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-03-17

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

IMPEL PHARMS

DIHYDROERGOTAMINE MESYLATE

Discovery on Target

Not Confirmed

IMPEL PHARMS

Country

Discovery on Target

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-01-23

DIHYDROERGOTAMINE MESYLATE

US Patent Number : 10940278

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 213436

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-01-23

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

04

IMPEL PHARMS

DIHYDROERGOTAMINE MESYLATE

Discovery on Target

Not Confirmed

IMPEL PHARMS

Country

Discovery on Target

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2032-09-05

DIHYDROERGOTAMINE MESYLATE

US Patent Number : 9550036

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 213436

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-09-05

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

05

IMPEL PHARMS

DIHYDROERGOTAMINE MESYLATE

Discovery on Target

Not Confirmed

IMPEL PHARMS

Country

Discovery on Target

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2032-12-25

DIHYDROERGOTAMINE MESYLATE

US Patent Number : 10507295

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 213436

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-12-25

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

06

IMPEL PHARMS

DIHYDROERGOTAMINE MESYLATE

Discovery on Target

Not Confirmed

IMPEL PHARMS

Country

Discovery on Target

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2036-11-05

DIHYDROERGOTAMINE MESYLATE

US Patent Number : 11266799

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 213436

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-11-05

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?